The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human administration of CEB-01, a novel drug delivery implant matrix, in patients with recurrent or locally advanced retroperitoneal soft tissue sarcoma (RPS) after surgery: Preliminary safety and pharmacokinetics report.
 
José Antonio Gonzalez
No Relationships to Disclose
 
Ana Sebio
Research Funding - PharmaMar
Expert Testimony - PharmaMar
Travel, Accommodations, Expenses - Lilly; PharmaMar; Sanofi
 
Paula Cerdà
Honoraria - PharmaMar; Sanofi
Speakers' Bureau - PharmaMar; Sanofi
Travel, Accommodations, Expenses - Amgen
 
Francesc Cano
Stock and Other Ownership Interests - CEBIOTEX; CEBIOTEX (I)
Research Funding - CEBIOTEX (Inst)
Patents, Royalties, Other Intellectual Property - CEBIOTEX; CEBIOTEX (Inst)
 
José Antonio Tornero
Stock and Other Ownership Interests - CEBIOTEX
Research Funding - CEBIOTEX (Inst)
Patents, Royalties, Other Intellectual Property - CEBIOTEX; CEBIOTEX (Inst)
Other Relationship - CEBIOTEX
 
Luc Marti
Employment - CEBIOTEX
Stock and Other Ownership Interests - CEBIOTEX
Patents, Royalties, Other Intellectual Property - CEBIOTEX
 
Jaume Mora
Consulting or Advisory Role - YmAbs Therapeutics Inc
Speakers' Bureau - YmAbs Therapeutics Inc
Expert Testimony - YmAbs Therapeutics Inc
Travel, Accommodations, Expenses - YmAbs Therapeutics Inc
 
Lucas Krauel
Stock and Other Ownership Interests - CEBIOTEX
 
Antonio Lopez-Pousa
Research Funding - CEBIOTEX (Inst)